Editorial: adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease
- PMID: 25303382
- DOI: 10.1111/apt.12966
Editorial: adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease
Comment on
-
Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease.Aliment Pharmacol Ther. 2014 Nov;40(9):1044-55. doi: 10.1111/apt.12940. Epub 2014 Sep 3. Aliment Pharmacol Ther. 2014. PMID: 25185992
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical